XHKG
0973
Market cap6.39bUSD
Sep 12, Last price
33.70HKD
Name
L'Occitane International SA
Chart & Performance
P/E
58.75
P/S
2.17
EPS
0.06
Div Yield, %
—
Shrs. gr., 5y
0.14%
Rev. gr., 5y
12.24%
Revenues
2.54b
+19.08%
Net income
94m
-18.43%
CFO
261m
-13.21%
Dividend
Oct 03, 20230.2552 HKD/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
L'Occitane International S.A., together with its subsidiaries, designs, manufactures, and retails various natural and organic ingredient-based cosmetics and well-being products. It offers perfumes, soaps, and fragrant products. The company also provides skincare, haircare, body and bath, makeup, floral water, beauty oils, and other products. In addition, it engages in the general warehousing business. The company markets and sells its products under the L'OCCITANE en Provence, Melvita, Erborian, L'Occitane au Brésil, LimeLife by Alcone, ELEMIS, and Sol de Janeiro brand names to final customers, as well as intermediates, such as distributors, wholesalers, TV show channels, and travel retailers. As of March 31, 2022, it operated 3,068 retail locations with 1,490 own retail stores. It also sells its products through online. L'Occitane International S.A. has operations in Japan, the United States, Hong Kong, China, France, Russia, the United Kingdom, Russia, Luxembourg, Brazil, Taiwan, and internationally. The company was founded in 1976 and is headquartered in Luxembourg City, Luxembourg. L'Occitane International S.A. is a subsidiary of L'Occitane Groupe S.A.
Valuation
Title EUR in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2024‑03 | 2023‑03 | 2022‑03 | 2021‑03 | 2020‑03 | 2019‑03 | 2018‑03 | 2017‑03 | 2016‑03 | |
| Income | |||||||||
Revenues | |||||||||
Cost of revenue | |||||||||
Unusual Expense (Income) | |||||||||
NOPBT | |||||||||
NOPBT Margin | |||||||||
Operating Taxes | |||||||||
Tax Rate | |||||||||
NOPAT | |||||||||
Net income | |||||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | |||||||||
BB yield | |||||||||
| Debt | |||||||||
Debt current | |||||||||
Long-term debt | |||||||||
Deferred revenue | |||||||||
Other long-term liabilities | |||||||||
Net debt | |||||||||
| Cash flow | |||||||||
Cash from operating activities | |||||||||
CAPEX | |||||||||
Cash from investing activities | |||||||||
Cash from financing activities | |||||||||
FCF | |||||||||
| Balance | |||||||||
Cash | |||||||||
Long term investments | |||||||||
Excess cash | |||||||||
Stockholders' equity | |||||||||
Invested Capital | |||||||||
ROIC | |||||||||
ROCE | |||||||||
| EV | |||||||||
Common stock shares outstanding | |||||||||
Price | |||||||||
Market cap | |||||||||
EV | |||||||||
EBITDA | |||||||||
EV/EBITDA | |||||||||
Interest | |||||||||
Interest/NOPBT | |||||||||